Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Sat Dec 16 13:24:22 GMT 2023
by
admin
on
Sat Dec 16 13:24:22 GMT 2023
|
| Source Materials Class | ORGANISM |
| Source Materials Type | MAMMAL |
| Source Materials Parent | |
| Part | PLASMA |
| Fraction Material Type | PROTEIN |
| Fraction Name | IGG |
| Record UNII |
475247QF1Z
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Related Record | Type |
|---|
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
L04AA03
Created by
admin on Sat Dec 16 13:24:22 GMT 2023 , Edited by admin on Sat Dec 16 13:24:22 GMT 2023
|
||
|
NCI_THESAURUS |
C2701
Created by
admin on Sat Dec 16 13:24:22 GMT 2023 , Edited by admin on Sat Dec 16 13:24:22 GMT 2023
|
||
|
NCI_THESAURUS |
C278
Created by
admin on Sat Dec 16 13:24:22 GMT 2023 , Edited by admin on Sat Dec 16 13:24:22 GMT 2023
|
||
|
WHO-VATC |
QL04AA03
Created by
admin on Sat Dec 16 13:24:22 GMT 2023 , Edited by admin on Sat Dec 16 13:24:22 GMT 2023
|
||
|
NDF-RT |
N0000184163
Created by
admin on Sat Dec 16 13:24:22 GMT 2023 , Edited by admin on Sat Dec 16 13:24:22 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
973
Created by
admin on Sat Dec 16 13:24:22 GMT 2023 , Edited by admin on Sat Dec 16 13:24:22 GMT 2023
|
PRIMARY | |||
|
N0000007920
Created by
admin on Sat Dec 16 13:24:22 GMT 2023 , Edited by admin on Sat Dec 16 13:24:22 GMT 2023
|
PRIMARY | Immunoglobulins [Chemical/Ingredient] | ||
|
475247QF1Z
Created by
admin on Sat Dec 16 13:24:22 GMT 2023 , Edited by admin on Sat Dec 16 13:24:22 GMT 2023
|
PRIMARY | |||
|
CHEMBL2108981
Created by
admin on Sat Dec 16 13:24:22 GMT 2023 , Edited by admin on Sat Dec 16 13:24:22 GMT 2023
|
PRIMARY | |||
|
SUB12913MIG
Created by
admin on Sat Dec 16 13:24:22 GMT 2023 , Edited by admin on Sat Dec 16 13:24:22 GMT 2023
|
ALTERNATIVE | |||
|
91601
Created by
admin on Sat Dec 16 13:24:22 GMT 2023 , Edited by admin on Sat Dec 16 13:24:22 GMT 2023
|
PRIMARY | |||
|
N0000020023
Created by
admin on Sat Dec 16 13:24:22 GMT 2023 , Edited by admin on Sat Dec 16 13:24:22 GMT 2023
|
PRIMARY | Antibody-Surface Protein Interactions [MoA] | ||
|
SUB12912MIG
Created by
admin on Sat Dec 16 13:24:22 GMT 2023 , Edited by admin on Sat Dec 16 13:24:22 GMT 2023
|
PRIMARY | |||
|
475247QF1Z
Created by
admin on Sat Dec 16 13:24:22 GMT 2023 , Edited by admin on Sat Dec 16 13:24:22 GMT 2023
|
PRIMARY | |||
|
N0000009689
Created by
admin on Sat Dec 16 13:24:22 GMT 2023 , Edited by admin on Sat Dec 16 13:24:22 GMT 2023
|
PRIMARY | Increased T Lymphocyte Destruction [PE] | ||
|
1011
Created by
admin on Sat Dec 16 13:24:22 GMT 2023 , Edited by admin on Sat Dec 16 13:24:22 GMT 2023
|
ALTERNATIVE | RxNorm | ||
|
N0000178327
Created by
admin on Sat Dec 16 13:24:22 GMT 2023 , Edited by admin on Sat Dec 16 13:24:22 GMT 2023
|
PRIMARY | Lymphocyte Function Alteration [PE] | ||
|
DB09312
Created by
admin on Sat Dec 16 13:24:22 GMT 2023 , Edited by admin on Sat Dec 16 13:24:22 GMT 2023
|
PRIMARY | |||
|
C80824
Created by
admin on Sat Dec 16 13:24:22 GMT 2023 , Edited by admin on Sat Dec 16 13:24:22 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SUB_CONCEPT->SUBSTANCE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| TARGETED ANTIGEN | IMMUNOLOGICAL |
|
HUMAN THYMOCYTE, AUTOLOGOUS | J56RKY13OV |